FumaraFer
Natural health product licensed in Canada
- Licence holder
- Avricore Health Inc.
- NPN or DIN-HM
- 80079773
- Status
- Inactive licence
- Licence date
- 30 August 2017
- Revision date
- 3 November 2017
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Fer Source : Fumarate de fer (II) | 97.5 milligramme | Not calculated |
Non-medicinal ingredients
Rouge FD&C no. 2, Dioxyde de silicium, Rouge FD&C No. 3, Lactose, Lauryl sulfate de sodium, D&C Jaune n° 10, Povidone, Sucrose, Jaune FD&C n° 6, Gélatine, Eau purifiée, Dioxyde de titane, Talc
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | 1 Capsule | 1 day |
Uses authorised in Canada
For the treatment of Iron Deficient Anemia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Consult a health care practitioner prior to use if you - have hereditary hemochromatosis, other conditions of iron overloading (including blood transfusions), peptic ulcer, regional enteritis, ulcerative colitis and/or other gastro-intestinal concerns. - experience symptoms of iron toxicity such as nausea, vomiting, abdominal pain, hematemesis (vomiting of blood) and discontinue usage. - are pregnant or breast-feeding. - want to use beyond 2 months.
- Précautions et mises en garde
Some people may experience constipation, diarrhoea, and/or vomiting. May cause abdominal cramping. FOR THERAPEUTIC USE ONLY. DO NOT USE EXCEPT UNDER THE CARE OF A PHYSICIAN. Keep put of reach of children. There is enough drug in this package to seriously harm a child. DO NOT USE IF THE SEAL UNDER CAP IS BROKEN; CHILD RESISTANT CAP.
- Effets indésirables connus
May experience constipation, diarrhoea, and/or vomiting.
Source
Official Health Canada record, licence 80079773
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.